NIH-funded research R01 grant

New treatment to protect the brain after a stroke in diabetic patients

Official title: Novel Pharmacological Approach to Stroke Neuroprotection

Funded at University of Tennessee Health Sci Ctr · NIH-11022258 · Data updated 2026-11-12

This study is looking at a new treatment that might help protect the brain after a stroke, especially for people with Type 2 diabetes, by using a special molecule to keep brain cells healthy and improve recovery.

More Stroke research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tennessee Health Sci Ctr
NIH-funded
Lab location1 site (Memphis, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$459,111
NIH project number1R01NS140100-01
Project IDNIH-11022258 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with Type 2 diabetes who are at risk of or have experienced an acute ischemic stroke.

Less likely to help

Patients without diabetes or those who have not experienced a stroke may not benefit from this research.

What this research studies

This research investigates a novel pharmacological approach to protect the brain from damage after a stroke, particularly in patients with Type 2 diabetes. It focuses on a small molecule called CDN1163 that activates a protein known as SERCA2, which helps regulate calcium levels in brain cells. By restoring normal calcium homeostasis, the treatment aims to reduce cell death and improve recovery from stroke-related complications. The study will involve animal models to assess the effectiveness of this treatment in preventing neurovascular damage.

Why it matters

Potential benefit: If successful, this research could lead to a new therapy that significantly improves recovery and reduces complications for diabetic patients who suffer a stroke.

How similar studies have gone: Previous research has shown promising results with similar approaches targeting calcium homeostasis in stroke recovery, indicating potential for success in this novel treatment.

Where this research is happening

  • University of Tennessee Health Sci Ctr
    Memphis, United States
    Active

Researchers

  • Principal investigator: Lebeche, Djamel — University of Tennessee Health Sci Ctr
  • Study coordinator: Lebeche, Djamel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.